NNLX Stock Overview
A biotechnology company, provides live cell and rapid diagnostics test kits that detects viable bacteria and other microorganisms. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
NanoLogix, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$0.000001 |
| 52 Week High | US$0.0001 |
| 52 Week Low | US$0.000001 |
| Beta | 0 |
| 11 Month Change | n/a |
| 3 Month Change | n/a |
| 1 Year Change | 0% |
| 33 Year Change | -99.50% |
| 5 Year Change | -100.00% |
| Change since IPO | -100.00% |
Recent News & Updates
Recent updates
Shareholder Returns
| NNLX | US Biotechs | US Market | |
|---|---|---|---|
| 7D | 0% | 4.3% | 1.6% |
| 1Y | 0% | 18.8% | 32.3% |
Return vs Industry: NNLX underperformed the US Biotechs industry which returned 18% over the past year.
Return vs Market: NNLX underperformed the US Market which returned 32.4% over the past year.
Price Volatility
| NNLX volatility | |
|---|---|
| NNLX Average Weekly Movement | n/a |
| Biotechs Industry Average Movement | 9.8% |
| Market Average Movement | 6.3% |
| 10% most volatile stocks in US Market | 16.2% |
| 10% least volatile stocks in US Market | 3.1% |
Stable Share Price: NNLX's share price has been volatile over the past 3 months compared to the US market.
Volatility Over Time: Insufficient data to determine NNLX's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| n/a | n/a | Bret Barnhizer | nanologix.com |
NanoLogix, Inc., a biotechnology company, provides live cell and rapid diagnostics test kits that detects viable bacteria and other microorganisms. The company’s products include BioNanoPore kit, which employs a water permeable membrane that works with organic and inorganic molecules, as well as proteins; and FlatPack Petri Plates that are used for the isolation and cultivation of various fastidious and non-fastidious microorganisms, as well as displays growth of aerobic and anaerobic microorganisms. Its products are used in medical, national defense, homeland security, pharmaceutical, industrial, veterinary, and environmental testing applications.
NanoLogix, Inc. Fundamentals Summary
| NNLX fundamental statistics | |
|---|---|
| Market cap | US$162.00 |
| Earnings (TTM) | -US$1.95m |
| Revenue (TTM) | US$1.27k |
0.0x
P/S Ratio0.0x
P/E RatioIs NNLX overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| NNLX income statement (TTM) | |
|---|---|
| Revenue | US$1.27k |
| Cost of Revenue | US$193.17k |
| Gross Profit | -US$191.90k |
| Other Expenses | US$1.76m |
| Earnings | -US$1.95m |
Last Reported Earnings
Jun 30, 2012
Next Earnings Date
n/a
| Earnings per share (EPS) | 0 |
| Gross Margin | 0.00% |
| Net Profit Margin | 0.00% |
| Debt/Equity Ratio | 0.0% |
How did NNLX perform over the long term?
See historical performance and comparison